| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.051 | 0.4 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.4 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |